Title:
NOVEL COMPOUND AND USE THEREOF IN TREATING PSORIASIS, ASTHMA, OR SYSTEMIC LUPUS ERYTHEMATOSUS
Document Type and Number:
WIPO Patent Application WO/2022/211518
Kind Code:
A1
Abstract:
The present invention pertains to a novel compound and a use thereof in treating psoriasis, asthma, or systemic lupus erythematosus. A pharmaceutical composition containing the novel compound of the present invention can not only control inflammation, but can also restore tissue homeostasis through immune balance and recovery from damaged tissues, and thus exhibits an excellent effect of treating and preventing psoriasis, asthma, or systemic lupus erythematosus.
Inventors:
SEO SU KIL (KR)
LEE SOUNG MIN (KR)
WON HAE JEONG (KR)
YOON EUN HYE (KR)
JANG WON HEE (KR)
LEE SOUNG MIN (KR)
WON HAE JEONG (KR)
YOON EUN HYE (KR)
JANG WON HEE (KR)
Application Number:
PCT/KR2022/004585
Publication Date:
October 06, 2022
Filing Date:
March 31, 2022
Export Citation:
Assignee:
PARENCHYMA BIOTECH INC (KR)
International Classes:
C07D401/12; A61K31/403; A61K31/428; A61K31/4439; A61P11/06; A61P17/06; A61P37/00; C07D209/18; C07D417/12
Domestic Patent References:
| WO2020150417A2 | 2020-07-23 | |||
| WO2018229195A1 | 2018-12-20 |
Foreign References:
| US5965582A | 1999-10-12 | |||
| KR101110404B1 | 2012-02-17 | |||
| KR20210040803A | 2021-04-14 |
Attorney, Agent or Firm:
LEECHAE INTELLECTUAL PROPERTY (KR)
Download PDF: